Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Home_Serve
gptkb:Hamburger_SV |
gptkbp:affects |
gptkb:skincare_product
mucous membranes |
gptkbp:associated_with |
stigma
immunocompromised individuals psychosocial issues neonatal herpes |
gptkbp:caused_by |
gptkb:genital_herpes
cold sores |
gptkbp:common_name |
gptkb:Herpes_Simplex_Virus
|
gptkbp:family |
gptkb:Herpesviridae
|
gptkbp:genus |
gptkb:Simplexvirus
|
gptkbp:healthcare |
impact on mental health
education on transmission requires awareness important health issue |
gptkbp:historical_event |
discovered in 1887
first isolated in 1930s |
https://www.w3.org/2000/01/rdf-schema#label |
HSV
|
gptkbp:is_protected_by |
safe sex practices
avoid direct contact during outbreaks |
gptkbp:lifespan |
latent infection
reactivation |
gptkbp:research |
genetic studies
vaccine development |
gptkbp:risk_factor |
skin-to-skin contact
weakened immune system multiple sexual partners |
gptkbp:seed_dispersal |
double-stranded DNA
approximately 152 kb |
gptkbp:social_responsibility |
PCR test
common worldwide high prevalence serological test |
gptkbp:symptoms |
fever
pain 1-2 weeks itching blisters chronic recurrences |
gptkbp:transmission |
direct contact
sexual contact |
gptkbp:treatment |
gptkb:drug
supportive care pain relief medications topical creams oral antivirals episodic therapy suppressive therapy |
gptkbp:type |
gptkb:HSV-1
gptkb:HSV-2 |
gptkbp:type_of |
gptkb:HSV-1
gptkb:HSV-2 |